After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Terns Pharmaceuticals Inc is $567.95M. A total of 1.26 million shares were traded on the day, compared to an average of 920.98K shares.
In the most recent transaction, Kuriakose Emil sold 853 shares of TERN for 4.27 per share on Jul 01 ’25. After the transaction, the Chief Medical Officer now owns 52,464 company shares. In a previous transaction on Jun 27 ’25, Gengos Andrew bought 10,000 shares at 3.93 per share. TERN shares that Chief Financial Officer owns now total 25,000.
Among the insiders who bought shares, Burroughs Amy L. acquired of 23,314 shares on Jun 25 ’25 at a per-share price of $3.87. This resulted in the Chief Executive Officer holding 47,083 shares of TERN after the transaction. In another insider transaction, Gengos Andrew bought 10,000 shares at $3.73 per share on Jun 13 ’25. Company shares held by the Chief Financial Officer now total 10,000.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TERN has a high of $11.40 and a low of $1.87.
As of this writing, TERN has an earnings estimate of -$0.29 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.28 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TERN’s latest balance sheet shows that the firm has $165.98M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $6.82M in liabilities at the time. Its Book Value Per Share was $3.49, while its Total Shareholder’s Equity was $160.30M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TERN is Buy with a score of 4.75.
